Literature DB >> 20308543

xCT deficiency accelerates chemically induced tumorigenesis.

Ami Nabeyama1, Ai Kurita, Kenichi Asano, Yasunobu Miyake, Takuwa Yasuda, Ikuo Miura, Gen Nishitai, Satoko Arakawa, Shigeomi Shimizu, Shigeharu Wakana, Hisahiro Yoshida, Masato Tanaka.   

Abstract

During the course of inflammation and its resolution, macrophages are exposed to various cytotoxic materials, including reactive oxygen species. Thus, macrophages require a protective machinery against oxidative stress to survive at the inflammatory site. Here, we showed that xCT, a component of transport system x(c)(-), was significantly up-regulated in activated infiltrating cells, including macrophages and neutrophils at the inflammatory site. System x(c)(-) mediates the uptake of extracellular L-cystine and is consequently responsible for maintenance of intracellular glutathione levels. We established a loss-of-function mouse mutant line of xCT by N-ethyl-N-nitrosourea mutagenesis. Macrophages from xCT(mu/mu) mice showed cell death in association with the excessive release of high mobility group box chromosomal protein 1 upon stimulation with LPS, suggesting that xCT deficiency causes unremitting inflammation because of the impaired survival of activated macrophages at the inflammatory site. Subcutaneous injection of 3-methylcholanthrene (3-MCA) induced the generation of fibrosarcoma in association with inflammation. When 3-MCA was injected s.c. into mice, xCT mRNA was up-regulated in situ. In xCT(mu/mu) mice, inflammatory cytokines (such as IL-1beta and TNFalpha) were overexpressed, and the generation of 3-MCA-induced fibrosarcoma was accelerated. These results clearly indicate that the defect of the protective system against oxidative stress impaired survival of activated macrophages and subsequently enhanced tumorigenecity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308543      PMCID: PMC2852021          DOI: 10.1073/pnas.0912827107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

2.  Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II Cells.

Authors:  Yasunobu Miyake; Hitomi Kaise; Kyo-Ichi Isono; Haruhiko Koseki; Kenji Kohno; Masato Tanaka
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

3.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

4.  Inhibition of cystine uptake disrupts the growth of primary brain tumors.

Authors:  Wook Joon Chung; Susan A Lyons; Gina M Nelson; Hashir Hamza; Candece L Gladson; G Yancey Gillespie; Harald Sontheimer
Journal:  J Neurosci       Date:  2005-08-03       Impact factor: 6.167

Review 5.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 6.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine.

Authors:  Gang Liu; Jing Wang; Young-Jun Park; Yuko Tsuruta; Emmanuel F Lorne; Xia Zhao; Edward Abraham
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.

Authors:  Jeremy B Swann; Matthew D Vesely; Anabel Silva; Janelle Sharkey; Shizuo Akira; Robert D Schreiber; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

10.  Induction of cystine/glutamate transporter in bacterial lipopolysaccharide induced endotoxemia in mice.

Authors:  Kumiko Taguchi; Michiko Tamba; Shiro Bannai; Hideyo Sato
Journal:  J Inflamm (Lond)       Date:  2007-09-26       Impact factor: 4.981

View more
  26 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

2.  The role of skeletal muscle in liver glutathione metabolism during acetaminophen overdose.

Authors:  L M Bilinsky; M C Reed; H F Nijhout
Journal:  J Theor Biol       Date:  2015-04-16       Impact factor: 2.691

Review 3.  Cancer Metabolism Drives a Stromal Regenerative Response.

Authors:  Simon Schwörer; Santosha A Vardhana; Craig B Thompson
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

4.  A fast workflow for identification and quantification of proteomes.

Authors:  Chen Ding; Jing Jiang; Junying Wei; Wanlin Liu; Wei Zhang; Mingwei Liu; Tianyi Fu; Tianyuan Lu; Lei Song; Wantao Ying; Cheng Chang; Yangjun Zhang; Jie Ma; Lai Wei; Anna Malovannaya; Lijun Jia; Bei Zhen; Yi Wang; Fuchu He; Xiaohong Qian; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2013-05-13       Impact factor: 5.911

Review 5.  Redox chemistry and chemical biology of H2S, hydropersulfides, and derived species: implications of their possible biological activity and utility.

Authors:  Katsuhiko Ono; Takaaki Akaike; Tomohiro Sawa; Yoshito Kumagai; David A Wink; Dean J Tantillo; Adrian J Hobbs; Peter Nagy; Ming Xian; Joseph Lin; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2014-09-16       Impact factor: 7.376

6.  Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.

Authors:  Takeo Goji; Kazuhiko Takahara; Manabu Negishi; Hironori Katoh
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

7.  Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Authors:  Kirsten S Evonuk; Brandi J Baker; Ryan E Doyle; Carson E Moseley; Christine M Sestero; Bryce P Johnston; Patrizia De Sarno; Andrew Tang; Igor Gembitsky; Sandra J Hewett; Casey T Weaver; Chander Raman; Tara M DeSilva
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

8.  Vascular anastomosis using controlled phase transitions in poloxamer gels.

Authors:  Edward I Chang; Michael G Galvez; Jason P Glotzbach; Cynthia D Hamou; Samyra El-ftesi; C Travis Rappleye; Kristin-Maria Sommer; Jayakumar Rajadas; Oscar J Abilez; Gerald G Fuller; Michael T Longaker; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

Review 9.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.